|
Match
|
Document |
Document Title |
|
|
7384628 |
Lactic acid bacteria and its use in direct-fed microbials
A composition comprising lactic acid bacteria that are selected from at least one of Lactococcus lactis, Lactobacillus lactis , and Lactobacillus brevis . The composition is suitable for...
|
|
|
7364740 |
Molecular differences between species of the M. tuberculosis complex
Specific genetic deletion are identified in mycobacteria isolates, including variations in the M. tuberculosis genome sequence between isolates, and numerous deletion present in BCG as compared...
|
|
|
7361497 |
Probiotic bacteria
Strains of probiotic bacteria, their isolation, characteristics and methods of use to prevent or treat carriage by a food production animal of Salmonella that causes human salmonellosis are...
|
|
|
7335352 |
Method of identifying agents that inhibit quorum sensing activity of gamma-proteobacteria
Screening assays that allow for the identification of agents that increase acyl homoserine lactone (AHL) acylase expression and/or AHL acylase activity in γ-proteobacteria such as Pseudomonas...
|
|
|
7323328 |
Obligately symbiotic thermophile Symbiobacterium toebii SC-1 producing thermostable L-tyrosine phenol-lyase and L-tryptophan indole-lyase
The present invention relates to a novel obligately symbiotic thermophile Symbiobacterium toebii SC-1 (Accession NO: KCTC 0685BP), and a thermostable L-tyrosine phenol-lyase and L-tryptophan...
|
|
|
RE40023 |
Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use
A pharmaceutical composition containing several different bacteria including Streptococcus thermophilus, Lactobacilli and Bifidobacteria is disclosed. The bacteria are present in the composition at...
|
|
|
7312065 |
Lawsonia intracellularis of European origin and vaccines, diagnostic agents and methods of use thereof
The present invention relates to Lawsonia intracellularis vaccines and methods for protecting against and diagnosing L. intracellularis infection. The products and processes of the invention...
|
|
|
7267816 |
Ammonia-oxidizing bacteria
Described herein are novel ammonia-oxidizing bacteria as well as isolated nucleotide sequences representative of 16S rDNA of these ammonia-oxidizing bacteria. Particular bacteria of the present...
|
|
|
7262151 |
Methods and compositions for production of lipo-chito oligosaccharides by rhizobacteria
Lipo-chito oligosaccharides (LCOs) are produced by culturing rhizobacteria cells in or on a culture medium comprising at least one of: jasmonic acid or a derivative thereof; linoleic acid or a...
|
|
|
7261899 |
Method of producing thy A-strains of Vibrio cholerae, such strains and their use
A method of producing a thy A − strain of vibrio cholerae comprising the step of site-directed mutagenesis in the V. cholerae chromosome at the locus of the thy A gene SEQ ID NO: 1 of FIG. 1...
|
|
|
7250162 |
Lactic acid bacteria inhibiting halitosis
The present invention relates to novel bacteria inhibiting halitosis or oral malodor. In particular, the present invention relates to novel lactic acid bacteria belonging to the genus Weissella ,...
|
|
|
7247296 |
Radiation therapy by accumulation of therapeutic radionuclides in tumor-targeting bacteria
The invention can be summarized as follows. According to the present invention there is provided an attenuated, tumour-targeting bacterium comprising a heterologous nucleotide sequence encoding a...
|
|
|
7244607 |
Chromobacterium subtsugae sp. nov. for control of insect pests
Chromobacterium suttsuga sp. nov., a new species of the genus Chromobacterium which possesses insecticidal activity, is described. The invention also relates to insecticidally-active metabolites...
|
|
|
7241441 |
Microorganism Pediococcus pentosaceus EROM101, having immune enhancement, anticancer and antimicrobial activities
The present invention relates to a novel Pediococcus genus microorganism and more particularly, Pediococcus pentosaceus EROM101 (KCCM-10517) originated from human intestines having immune...
|
|
|
7241439 |
Biopesticide compositions
The present invention relates to compositions suitable for use against one or more pathogens comprising at least one antagonistic micro-organism and at least one stimulating agent, which may be...
|
|
|
7238345 |
Recombinant microorganism expressing meningococcal class 1 outer membrane protein
Outer-membrane vesicles, Class 1 outer membrane proteins of Neisseria meningitidis, fragments or oligopeptides containing epitopes of the Class I OMP can be used to immunize against meningococcal...
|
|
|
7235395 |
Lactic acid bacteria as agents for treating and preventing allergy
The present invention pertains to novel strains of lactic acid bacteria capable of reducing an individual's tendency to react allergic against a variety of different allergens. In particular, the...
|
|
|
7235234 |
Bacterial delivery system
We describe a bacterial delivery system for the delivery of DNA and antigens into cells. We constructed an attenuated bacterial vector which enters mammalian cells and ruptures delivering...
|
|
|
7229616 |
Lactic acid bacteria for the treatment and/or prophylaxis of giardiasis
The present invention relates to the use of a supernatant of lactic acid bacteria or of Bifidobacteria capable of preventing colonization of intestinal cells by Giardia intestinalis , for the...
|
|
|
7226590 |
Antimicrobial composition
This invention provides novel Streptococcus salivarius, compositions containing same, and use of S. salivarius strains as antimicrobial agents. The strains are bacterial inhibitors with respect...
|
|
|
7223591 |
Strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it
Describes a new strain of Streptococcus thermophilus ssp. salivarius (deposited on 4 Dec. 2001 at the DSMZ—Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, Braunschweig, Germany,...
|
|
|
7204993 |
Streptococcus agalactiae vaccine
A composition prepared from intact killed cells of isolated β-hemolytic Streptococcus agalactiae and a concentrated extract of a culture of β-hemolytic Streptococcus agalactiae , is effective...
|
|
|
7198785 |
Systems and methods related to degradation of uremic toxins
The present invention generally relates to the treatment of uremic toxins in vivo using uremic toxin-treating enzymes, and/or cells capable of producing uremic toxin-treating enzymes or otherwise...
|
|
|
7195906 |
Bifidobacterium in the treatment of inflammatory disease
A strain of Bifidobacterium isolated from resected and washed human gastrointestinal tract is significantly immunomodulatory following oral consumption in humans. The strain is useful in the...
|
|
|
7189557 |
Process for the intracellular over-production of streptokinase using genetically engineered strain of E. coli
An improved process for the production of streptokinase using a genetically engineered strain of Escherichia coli which overproduces streptokinase intracellularly and more particularly, the...
|
|
|
7172762 |
Erysipelothrix rhusiopathiae antigens and vaccine compositions
The invention relates to stabilized antigen compositions of Erysipelothrix rhusiopathiae and vaccine formulations containing such antigen compositions. Antigens of the invention are effective in...
|
|
|
7169394 |
Mycoplasma hyopneumoniae bacterin vaccine
The invention provides an improved Mycoplasma hyopneumoniae bacterin vaccine composition, which advantageously provides immunity from infection after a single administration. The composition...
|
|
|
7169383 |
Attaching substances to micro-organisms
The invention relates to surface display of proteins on micro-organisms via the targeting and anchoring of heterologous proteins to the outer surface of cells such as yeast, fungi, mammalian and...
|
|
|
7163820 |
Escherichia coli strain for an oral vaccine against post-weaning diarrhea in pigs
The invention relates to a strain suitable for producing a live, orally applicable Escherichia coli vaccine for the prevention of post-weaning diarrhoea in pigs, and the procedure suitable for...
|
|
|
7157258 |
Particles containing coated living micro-organisms, and method for producing same
Particles containing dehydrated living micro-organisms are coated with a homogeneous layer of hydrophobic substance selected to reduce the risks of degradation of the micro-organisms by...
|
|
|
7144723 |
Marine actinomycete taxon for drug and fermentation product discovery
The invention is the discovery of an actinomycete genus, given the name Salinospora gen. nov., that displays an obligate requirement of seawater (Na + ) for growth and unique 16S rRNA signature...
|
|
|
7141395 |
Biological control of crown gall disease
The present invention provides a method for controlling crown gall disease in plants using an effective quantity of α-proteobacteria that produces trifolitoxin (TFX). The present invention also...
|
|
|
7118739 |
Biocontrol of plant diseases caused by Fusarium species with novel isolates of Pantoea agglomerans
Microbiological agents are provided for control of certain diseases of wheat and other cereals caused by Fusarium species, including Fusarium head blight of wheat and other cereals. These...
|
|
|
7105317 |
Immunogenic compositions comprising vrg-gene products from Bordetella extracts
This invention relates to an immunogenic composition comprising a bacterial extract containing at least one expression products of the vrg genes of a strain of Bordetella chosen from B....
|
|
|
7101558 |
High yield pertussis vaccine production strain and method for making same
The present invention provides a vaccine production strain of Bordetella bronchiseptica that produces a pertussis toxin in high yield. The present invention provides a method for creating a ...
|
|
|
7097831 |
α-Amylase-resistant starch for producing foodstuff and medicaments
The invention relates to foodstuff and animal feed which contain resistant starch on the basis of water-insoluble linear α-1,4-D-glucans. The invention also related to the utilization of resistant...
|
|
|
7094410 |
DNA vaccine against proliferating endothelial cells and methods of use thereof
A DNA vaccine effective for inhibiting endothelial cell proliferation comprises a DNA construct operably encoding a vascular endothelial growth factor (VEGF) receptor protein. This invention...
|
|
|
7090875 |
External skin preparations and process for producing the same
External skin preparations containing one or more members selected from among a fermentation product, which is obtained by treating a bean extract with a microorganism, vitamin A and its...
|
|
|
7090839 |
Method of treatment of human immunodeficiency diseases
The present invention relates to a method of treating human immunodeficiency diseases with electroactivated aqueous salt solutions followed by reconstitution of a healthy microflora.
|
|
|
7090838 |
Bacterium NRRL B-30043 for controlling algae
A method of reducing or eliminating off-flavor in water or fish by controlling cyanobacteria or algae in the water wherein cyanobacteria or algae produce agents that cause the off-flavor. The...
|
|
|
7078191 |
Composition and method for the detection of diseases associated with amyloid-like fibril or protein aggregate formation
The present invention relates to novel compositions useful for elucidating the onset or progress of diseases such as Huntington's disease, that are associated with the formation of fibrils or...
|
|
|
7067122 |
Modified live Edwardsiella tarda vaccine for aquatic animals
A safe and effective live vaccine against Edwardsiella tarda in fish was created through the induction of rifampicin resistance in a native Edwardsiella tarda isolate. Single immersion exposure...
|
|
|
7063974 |
Baroduric bacterium from Indian Ocean
Accordingly the present invention provides a process for the preparation an alcoholic extract with Carotenoids, UV absorption, antibacterial and pH indicating properties from a deep-sea bacterium...
|
|
|
7063836 |
Compositions and methods for inhibiting pathogenic growth
The invention includes methods and compositions for treating an animal to inhibit the incidence and growth of E. coli O157:H7 and other pathogenic bacteria. The treatment method comprises...
|
|
|
7056492 |
Mycoplasma hyopneumoniae vaccine and methods for reducing Mycoplasma bovis pneumonia in cattle
The present invention relates to methods for treating or preventing a disease or disorder in an animal caused by infection by Mycoplasma bovis ( M. bovis ) by administering to the animal an...
|
|
|
7037708 |
Dried microorganism cultures and method for producing same
Dry microorganism cultures comprising at least one microorganism species in carrier-bound form are present in the form of particles which a) have a particle size of at least about 0.1 mm and b) are...
|
|
|
7037494 |
Formulations and methods for insect control
A composition is disclosed from controlling an insect population including an insect food stuff and an insecticidally effective amount of at least one Gram negative bacteria, viable, dead or alive,...
|
|
|
7033587 |
Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair
Methods and compositions for directing adipose-derived stromal cells cultivated in vitro to differentiate into cells of the chondrocyte lineage are disclosed. The invention further provides a...
|
|
|
7029702 |
Method for increasing lactose tolerance in mammals exhibiting lactose intolerance
The method for increasing lactose tolerance in subjects exhibiting lactose intolerance symptoms implements a protocol where the subjects ingest a gradually increasing amount of lactose containing...
|
|
|
7026160 |
Oral bacteriotherapy compositions and methods
A composition for treatment of renal failure with selected bacteria which converts nitrogenous waste into non-toxic compounds in vivo is provided. Also provided is a method of inhibiting build up...
|